The raised guidance and strong Cigna Healthcare margins support the bullish thesis, but the persistent weakness in Pharmacy Benefit Services (down 22% YoY) and the planned exit from Individual and Family Plans (IFP) medical business warrant monitoring. The Investor Day long-term targets (10-14% EPS CAGR, $50B cumulative OCF) provide a strategic framework; execution on the Accelerate to One productivity initiative will be key to sustaining margins.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $301.48entry
- T+1 · 11d ago −2.62%α −2.93% · $293.59
- T+5 · 5d ago −1.73%α −5.02% · $296.27
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Cigna reported Q3 2026 adjusted EPS of $7.98, above the $7.51 consensus, and total revenue of $73.7B, above the $72.45B consensus. The company raised its full-year 2026 adjusted EPS outlook to at least $30.60, up from at least $30.35, driven by strong Cigna Healthcare results and disciplined execution.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $73.7B, +6% YoY, above $72.45B consensus
- Q3 2026 adjusted EPS $7.98, above $7.51 consensus estimate
- Full-year 2026 adjusted EPS outlook raised to at least $30.60 from at least $30.35
- Cigna Healthcare segment adjusted income from operations pre-tax up 15% YoY to $1.193B
- Evernorth Health Services adjusted revenue +6% YoY to $63.8B, but segment operating income -4% YoY
- Pharmacy Benefit Services adjusted operating income down 22% YoY due to large client contract renewals
- Year-to-date through Nov 4 repurchased 1.8M shares for ~$500M
- Company hosted 2026 Investor Day, introduced 10%-14% adjusted EPS CAGR target and ~$50B cumulative operating cash flow through 2030
Financial Impact
Q3 adjusted EPS $7.98 vs consensus $7.51 (+6.3% beat); revenue $73.7B vs $72.45B (+1.7% beat); FY2026 guidance raised by $0.15 to at least $30.60
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Evernorth Health Services | $63.8B | +5.6% |
| Cigna Healthcare | $11.7B | +8.9% |
Risk Factors
- Pharmacy Benefit Services margin compression from large client renewals and strategic investments
- Planned exit from Individual and Family Plans medical business as of Jan 1, 2027 creates uncertainty
- Total customer relationships down 6% from Dec 2025 due to pharmacy and behavioral customer losses
- Behavioral care customers down 19% from Dec 2025 due to termination of a government contract
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-042030 |
| Document: ef20084818_8k.htm | 0001140361-26-042030 |
| Document: 0001140361-26-042030-index-headers.html | 0001140361-26-042030 |
| Document: 0001140361-26-042030-index.html | 0001140361-26-042030 |
| Document: 0001140361-26-042030.txt | 0001140361-26-042030 |
| 8-K Data (Synthetic) | 0001140361-26-042030 |
Track record
16 reports on CI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $301.48 to $296.27 Now $297.00 −1.49% ▼ −1.73% −5.02% vs SPY
- Oct 28, 202619d ago Press Release Neutral 2/10 Entry $298.41 to $301.48 Now $297.00 −0.47% ▲ +1.03% +5.75% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $295.00 to $305.41 Now $297.00 +0.68% ▲ +3.53% +4.24% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $304.37 to $298.28 Now $297.00 −2.42% ▼ −2.00% −1.56% vs SPY
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $283.34 to $298.50 Now $297.00 +4.82% ▲ +5.35% +6.84% vs SPY
- Sep 30, 20266w ago 8-K Neutral 4/10 Entry $271.83 to $278.51 Now $297.00 +9.26% ▲ +2.46% +0.54% vs SPY
- Sep 3, 202610w ago 144 Neutral 2/10 Entry $286.26 to $280.76 Now $297.00 +3.75% ▼ −1.92% −0.77% vs SPY
- Aug 18, 202612w ago 144 Neutral 2/10 Entry $278.50 to $279.32 Now $297.00 +6.64% ▲ +0.29% +0.50% vs SPY
- Aug 4, 202614w ago 144 Neutral 2/10 Entry $273.45 to $273.87 Now $297.00 +8.61% ▲ +0.16% +0.25% vs SPY
- Jul 9, 202618w ago 3 Neutral 2/10 Entry $293.46 to $283.82 Now $297.00 +1.21% ▼ −3.28% −2.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers